AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Thomas Ginsberg
Sep. 1--Federal regulators approved a third flu vaccine yesterday for distribution to Americans, hoping to avoid a last-minute shortage like last winter.
The Food and Drug Administration also said a California drugmaker has made progress in fixing manufacturing problems from last year, possibly reopening another source of vaccines.
The FDA's fast-track approval of Fluarix, made by GlaxoSmithKline P.L.C. in Germany and already sold overseas, will add at least 8 million doses to the country's stockpile.
The FDA approval for London-based GlaxoSmithKline, whose U.S. operations are located in Philadelphia, would bring the total doses to 61 million-71 million, officials have said.